Jonathan Larsen, a Law and Policy Analyst at the Center for Public Health Law Research, has been announced as one of 40 under 40 in Cancer, an award program develped by the Lynx Group in 2018 to honor emerging leaders in cancer. Honorees are selected by a panel of reviewers from across diverse roles in oncology for their contributions in the field.
Nominations come from across the country and represent the following categories:
- Biopharma, Diagnostics, and Devices
- Clinical and Patient Care Professional
- Government, Regulatory, and Payer
- Patient Advocacy and Policy
- Research, Science, and Technology
Before returning to Temple University and the Center for Public Health Law Research in 2020, Larsen spent the last four years as a health policy consultant, providing federal and state legislative and regulatory analysis for biopharma clients. Larsen has broad health policy experience, particularly in oncology, having served in policy roles at the American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network (NCCN), where he also managed international business development. Outside of oncology, Larsen has worked on public policy initiatives at the National Osteoporosis Foundation (NOF) and was a senior compliance specialist at PerformRx, a pharmacy benefit management company, where he applied deep expertise across a continuum of Medicare Part D issues. Larsen has worked on issues related to biosimilars, molecular testing, the use of health data, medical guidelines, cancer prevention, health disparities, access to care, payment reform, and the initial rollout of the Affordable Care Act.
Larsen holds a JD from Temple University’s Beasley School of Law, an MPP from George Mason University’s Schar School of Policy and Government, where he was a Bryce Harlow Foundation Fellow, and a BA from Tufts University.
The virtual award ceremony will be held on Wednesday, December 1, at 6:30 pm ET. For more information, visit https://www.40under40incancer.com/